Tuberculosis patients are characterized by a low-IFN-γ/high-TNF-γ response to methylated HBHA produced in M. smegmatis

Diagnostic Microbiology and Infectious Disease

Volumn 71, Issue 4, 2011, Pages 449-452

  Molicotti, Paola ^a   Bua, Alessandra ^a   Cubeddu, Marina ^a   Cannas, Sara ^a   Delogu, Giovanni ^b   Zanetti, Stefania ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

HBHA; IFN; TNF; Tuberculosis

Indexed keywords

GAMMA INTERFERON; HEMAGGLUTININ; HEPARIN BINDING HEMAGGLUTININ; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CELL SPECIFICITY; CELLULAR IMMUNITY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFECTION; METHYLATION; MYCOBACTERIUM SMEGMATIS; PRIORITY JOURNAL; TUBERCULOSIS;

BACTERIAL PROTEINS; CELLS, CULTURED; HUMANS; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; MEMBRANE PROTEINS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; RECOMBINANT PROTEINS; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 82555164631     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2011.08.010     Document Type: Article

References (18)

1. Caccamo N., Guggino G., Joosten S.A., Gelsomino G., Di C.P., Titone L., et al. Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection. Eur. J. Immunol. 2010, 40:2211-2220.
2. Delogu G., Bua A., Pusceddu C., Parra M., Fadda G., Brennan M.J., et al. Expression and purification of recombinant methylated HBHA in Mycobacterium smegmatis. FEMS Microbiol. Lett. 2004, 239:33-39.
3. Delogu G., Chiacchio T., Vanini V., Butera O., Cuzzi G., Bua A., et al. Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders. PLoS ONE 2011, 6:e1815.
4. Diel R., Goletti D., Ferrara G., Bothamley G., Cirillo D., Kampmann B., et al. Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur. Respir. J. 2011, 37:88-99.
5. Diel R., Loddenkemper R., Niemann S., Meywald-Walter K., Nienhaus A. Negative and positive predictive value of a whole-blood interferon-{gamma} release assay for developing active tuberculosis: an update. Am. J. Respir. Crit. Care Med. 2011, 183:88-95.
6. Goletti D., Butera O., Vanini V., Lauria F.N., Lange C., Franken K.L., et al. Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection. Eur. Respir. J. 2010, 36:135-142.
7. Goletti D., Raja A., hamed Kabeer B.S., Rodrigues C., Sodha A., Butera O., et al. IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis. J. Infect. 2010, 61:133-143.
8. Harari A., Rozot V., Enders F.B., Perreau M., Stalder J.M., Nicod L.P., et al. Dominant TNF-alpha(+) Mycobacterium tuberculosis-specific CD4(+) T cell responses discriminate between latent infection and active disease. Nat. Med. 2011, 17:372-376.
9. Hougardy J.M., Place S., Hildebrand M., Drowart A., Debrie A.S., Locht C., et al. Regulatory T cells depress immune responses to protective antigens in active tuberculosis. Am. J. Respir. Crit. Care Med. 2007, 176:409-416.
10. Hougardy J.M., Schepers K., Place S., Drowart A., Lechevin V., Verscheure V., et al. Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis. PLoS ONE 2007, 2:e926.
11. Masungi C., Temmerman S., Van Vooren J.P., Drowart A., Pethe K., Menozzi F.D., et al. Differential T and B cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis. J. Infect. Dis. 2002, 185:513-520.
12. Pai M. Spectrum of latent tuberculosis - existing tests cannot resolve the underlying phenotypes. Nat. Rev. Microbiol. 2010, 8:242.
13. Pai M., Zwerling A., Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann. Intern. Med. 2008, 149:177-184.
14. Sutherland J.S., Adetifa I.M., Hill P.C., Adegbola R.A., Ota M.O. Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur. J. Immunol. 2009, 39:723-729.
15. Sutherland J.S., de Jong B.C., Jeffries D.J., Adetifa I.M., Ota M.O. Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort. PLoS ONE 2010, 5:e12365.
16. Temmerman S., Pethe K., Parra M., Alonso S., Rouanet C., Pickett T., et al. Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin. Nat. Med. 2004, 10:935-941.
17. Wallis R.S., Pai M., Menzies D., Doherty T.M., Walzl G., Perkins M.D., et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 2010, 375:1920-1937.
18. Zanetti S., Bua A., Delogu G., Pusceddu C., Mura M., Saba F., et al. Patients with pulmonary tuberculosis develop a strong humoral response against methylated heparin-binding hemagglutinin. Clin. Diagn. Lab. Immunol. 2005, 12:1135-1138.